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Purpose: To report our initial clinical cases of robotic laparoendoscopic single-site 
(R-LESS) partial nephrectomy (PN) performed with the use of the novel Da Vinci 
R-LESS platform.
Materials and Methods: Three patients underwent R-LESS PN from November 2013 
through February 2014. Perioperative and postoperative outcomes were collected and 
intraoperative difficulties were noted.
Results: Operative time and estimated blood loss volume ranged between 100 and 110 
minutes and between 50 and 500 mL, respectively. None of the patients was transfused. 
All cases were completed with the off-clamp technique, whereas one case required con-
version to the conventional (multiport) approach because of difficulty in creating the 
appropriate scope for safe tumor resection. No major postoperative complications oc-
curred, and all tumors were resected in safe margins. Length of hospital stay ranged 
between 3 and 7 days. The lack of EndoWrist movements, the external collisions, and 
the bed assistant’s limited working space were noticed to be the main drawbacks of this 
surgical method.
Conclusions: Our initial experience with R-LESS PN with the novel Da Vinci platform 
shows that even though the procedure is feasible, it should be applied in only appropri-
ately selected patients. However, further improvement is needed to overcome the exist-
ing limitations.
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INTRODUCTION
Increasing experience in minimally invasive techniques 
has furthered an impetus in the urological community to 
reduce the invasiveness of laparoendoscopic renal surgery. 
Therefore, robotic laparoendoscopic single-site (R-LESS) 
partial nephrectomy (PN) has been introduced in an effort 
to achieve a cosmetic outcome superior to that of the con-
ventional approach [1]. However, R-LESS PN is still more 
challenging and more complicated for surgeons than is con-
ventional RPN, because the current Da Vinci robotic plat-
form (Intuitive Surgical Inc., Sunnyvale, CA, USA) is not 
designed to be used in this kind of procedure [2]. 
In our practice, we have commonly used a homemade de-
vice adapted to an Alexis wound retractor to perform 
R-LESS PN [3]. However, we have experienced many diffi-
culties during surgery, such as fragility of the device, sig-
nificant gas leaks, and collision of the internal and external 
instruments [3]. Recently, Intuitive Surgical Inc. devel-
oped and commercialized the Da Vinci R-LESS device and 
instruments with a goal of decreasing the surgical limi-
tations that occur during the utilization of the available 
single-port devices [4]. 
Although the new technology has been tested in a few 
urological procedures, to our knowledge, experience with 
R-LESS PN through use of the novel Da Vinci platform has 
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FIG. 1. Computed tomography imaging of the tumors in cases 1 (A), 2 (B), and 3 (C). The white arrows show the tumors.
not yet been published [5-7]. In this study, we report our 
initial experience with this technology. 
MATERIALS AND METHODS 
1. Selection of patients and outcome measurements 
Since November 2013, a prospective analysis of the initial 
three patients who underwent R-LESS PN with use of the 
Da Vinci R-LESS platform was entered into an Institutio-
nal Review Board-approved database. Patient selection 
was based on the surgeon’s clinical judgment. All tumors 
were identified on abdominal computed tomography scans. 
Perioperative and postoperative data were collected and 
analyzed. Both the PADUA and RENAL scoring systems 
were used to account for tumor complexity [8,9]. Each pa-
tient’s estimated glomerular filtration rate (eGFR) was de-
termined by using the Modification of Diet in Renal Disease 
formula [10]. Complications were recorded within 30 days 
postoperatively by using the modified Clavien-Dindo clas-
sification system [11]. Operative time was defined as the 
overall time that the surgeon needed to start and complete 
the operation, without including the docking process. 
2. The Da Vinci Si R-LESS platform 
The Da Vinci R-LESS access device is a soft, silicon, 
reel-shaped port with four channels. Two channels accom-
modate curved cannulae for the flexible robotic instru-
ments (VeSPA surgical instruments, Intuitive Surgical 
Inc.), and the third and fourth channels remain for the lapa-
roscope and the assistant’s instrument. The left robotic in-
strument is directed downward to the right, whereas the 
right one is directed downward to the left. Although the ro-
botic instruments are crossed at the entrance site, the in-
struments are automatically reassigned by the system 
software, such that the left hand of the surgeon’s control 
directs the left instrument and vice versa. The develop-
ment of this “chopstick” surgical device hypothetically re-
sults in fewer collisions of the robotic arms [12]. 
3. Surgical technique
After induction of general endotracheal anesthesia, the pa-
tients were placed in a 45-degree flank position with the 
ipsilateral side elevated and were secured to the operating 
table after the pressure points were padded. The table was 
tilted to position the patient supine and a 2.5-cm midline 
periumbilical incision was made and dissected deep to the 
rectus fascia, down through the peritoneum. Access to the 
peritoneum was then obtained and the Da Vinci single-port 
device was inserted through the incision in the peritoneal 
cavity. 
Pneumoperitoneum was established up to 15 mmHg and 
the camera port was inserted. A 30o camera viewing angle 
was used to minimize clashing between the robotic scope 
and instruments externally. The Da Vinci Si system was 
docked by using a 3-arm configuration and the curved can-
nulae ports were inserted and docked under vision. 
Robotically controlled instruments included a semirigid 
cautery hook, curved scissors, needle holders, and a 
Cadiere grasper. During the procedure, the bedside assis-
tant had the ability to use a suction irrigator, a laparoscopic 
grasper, and a clip applier. The surgical steps included tu-
mor identification, tumor excision, and renorrhaphy by us-
ing the sliding clip technique. Laparoscopic ultrasound 
with TilePro projection (Intuitive Surgical Inc.) onto the 
console screen was introduced through the assistant port 
to confirm the tumor margin and depth. Frozen biopsies of 
renal parenchyma from the base of the operative bed were 
always obtained. Our surgical technique is demonstrated 
in a supplementary video clip (Supplementary material). 
RESULTS 
Case 1 had a 2.3-cm tumor located on the lower pole of the 
left kidney, case 2 a 2-cm mass located on the mid portion 
of the left kidney, and case 3 a 2-cm tumor on the lower pole 
of the right kidney (Fig. 1A–C). 
The clinical and demographic characteristics of the three 
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TABLE 1. Baseline characteristics of the patients
               Characteristic Case 1 Case 2 Case 3
Procedure November 2013 January 2014 February 2014
Age (y) 56 49 55
Gender Male Female Female
Body mass index (kg/m2) 25.2 26.1 21.0
ASA score 2 1 2
Comorbidities None None Hypertension
Previous surgery None Hysterectomy Hysterectomy
Laterality Left Left Right
Tumor size (cm) 2.3 2 2
Location Posterior medial Posterior lateral Posterior medial
RENAL score 4 6 5
PADUA score 7 7 7
pTNM stage T1aN0M0 T1aN0M0 T1aN0M0
Pathology Clear cell RCC Clear cell RCC Clear cell RCC
ASA, American Society of Anesthesiologists; RCC, renal cell carcinoma.
TABLE 2. Perioperative and postoperative outcomes of patients
               Variable Case 1 Case 2 Case 3
Operative time (min) 100 105 110
Estimated blood loss (mL) 200 50 500
Preoperative hemoglobin 15.9 13.6 13.9
Postoperative hemoglobin 14.1 12.3 11.4
Transfusion No No No
Preoperative eGFR (mL/min/1.73 m2) 90 89 90
Latest eGFR (mL/min/1.73 m2) 77 87 90
Positive surgical margins No No No
Clavien-Dindo complications None Grade I None
Conversion No No Yes
Hospitalization (d) 3 7 4
eGFR, estimated glomerular filtration rate.
patients are summarized in Table 1. All the tumors were 
located on the posterior surface of the kidneys and the renal 
scores were 4, 6, and 5, respectively. 
All the procedures were completed without clamping the 
renal vessels. No additional ports were used in any case. 
Operative time ranged from 100 to 110 minutes, and esti-
mated blood loss volume ranged from 50 to 500 mL. None 
of the patients was transfused. We did not detect positive 
surgical margins in any of the cases. One patient (case 2) 
developed atelectasis, which resulted in prolonged hospi-
talization (a grade I complication according to the Clavien- 
Dindo classification system). One case (case 3) was con-
verted to a multiport procedure owing to intraoperative dif-
ficulty of resecting the tumor. Table 2 shows the perioper-
ative and postoperative outcomes of the subjects. 
DISCUSSION
The Da Vinci R-LESS platform (Intuitive Surgical Inc.) has 
recently been used for pyeloplasty and radical neph-
rectomy procedures [5-7]. However, regarding R-LESS PN, 
only procedures performed in cadaver models have been 
described with the use of the novel Da Vinci platform [13]. 
RPN remains a challenging procedure even for the conven-
tional approach; therefore, it is difficult to apply novel tech-
niques in humans. To our knowledge, the current study is 
the first report of clinical experience with PN by use of this 
new technology. 
According to the literature, LESS surgery is technically 
feasible and safe for various urologic diseases, results in 
better cosmetic outcome, has a lower postoperative an-
algesic requirement, and is associated with faster con-
valescence than is conventional laparoscopy [1,14]. How-
ever, the oncological and surgical safety of a procedure is 
more important. In a recently published article, we demon-
strated that safety, estimated with Trifecta achievement, 
is inferior in R-LESS PN compared with the conventional 
approach [3]. Therefore, we concluded that R-LESS PN in 
the current fashion should be offered only to selected pa-
tients with low complexity and small tumors. These results 
were also reported by other studies, whereas European as-
sociation guidelines recommend that LESS PNs should be 
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performed only as part of a clinical study [15,16]. This is 
logical, because it is admitted worldwide that the current 
Da Vinci system (Intuitive Surgical Inc.) is not designed to 
be used in this kind of procedure. 
Intuitive Surgical Inc. developed a novel set of single-site 
instruments and accessories specifically dedicated to 
LESS in an attempt to overcome the current limitations [4]. 
However, the drawbacks of the existing configuration of ro-
botic arms and the use of a bulky robot in this kind of sur-
gery remain. Therefore, although the current Da Vinci 
platform has been shown to be a valuable ally in LESS sur-
gery, the ideal robotic platform for LESS is still lacking and 
more advanced equipment is requisite. 
According to our experience, even though the procedures 
were performed safely, we encountered many difficulties 
during the surgery. First, the lack of EndoWrist technology 
at the instrument tips results in difficult tumor excision 
and renal bed reconstruction, while intracorporeal sutur-
ing is more challenging. Second, the availability of monop-
olar and bipolar instruments is limited. Moreover, the ex-
ternal collisions of the instruments and the restricted as-
sistant’s motions due to the narrow space make the hilum 
dissection and the specimen extraction more complicated. 
In addition, we observed a frequent loss of pneumo-
peritoneum, as a result of leakage from the device, and frag-
ile material. Finally, the inability to use the fourth robotic 
arm makes the resection of posteriorly located tumors 
harder owing to the insufficient tissue retraction. As a re-
sult, we needed to convert one case into a conventional ap-
proach, although tumor complexity was not a deterrent for 
R-LESS surgery. 
Gas leakage and tearing of the device were also reported 
by Kroh et al. [17], and almost all studies refer to the lack 
of EndoWrist movements, the bed assistant’s limited work-
ing space, and the multiple collisions between the robotic 
arms as the main drawbacks [7,13]. In our opinion, im-
provement of the current R-LESS surgery to overcome 
these limitations can be achieved with the development of 
articulating instruments, a device with resistant material 
and a low external profile and wider internal rim, and re-
positioning of the assistant port below the camera port. The 
30o laparoscope is also necessary to minimize internal con-
flicts between the surgical instruments and the optical 
system.
CONCLUSIONS
R-LESS PN in the current design can be effectively per-
formed in centers with significant expertise, but careful pa-
tient selection appears to be a very important conside-
ration. However, further significant improvements, along 
with more studies, are needed to develop the ideal R-LESS 
robotic platform. The development of novel platforms spe-
cific for R-LESS surgery is essential to overcome the cur-
rent limitations and to promote the widespread use of this 
system. 
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SUPPLEMENTARY MATERIALS
Accompanying video clip can be found in the ‘Urology in 
Motion’ section of the journal homepage (www.kjurology.org). 
The supplementary video clip can also be accessed by scanning 
a QR code located on the title page of this article, or be available 
on YouTube (http://youtu.be/XdlmCuw3Er8).
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